
zzso zzso zzso zzso and zzso are zzso drugs formulated with zzso 80 for intravenous zzso We have previously reported that zzso including zzso 80 and zzso zzso can reverse the zzso resistance zzso zzso in an experimental system and that plasma zzso zzso zzso measured following a zzso infusion of zzso were zzso or zzso 1 zzso sufficient to zzso zzso in zzso The purpose of this study was to measure zzso 80 plasma zzso in patients following intravenous administration of zzso or zzso using a zzso in which zzso cells are incubated with zzso zzso plus 50/50 growth zzso and equilibrium zzso zzso zzso is measured by flow zzso In zzso experiments show zzso reversal of zzso at zzso of zzso zzso and 50% reversal at zzso zzso Patients received zzso at 75 zzso (five zzso or 100 zzso (four zzso zzso dose zzso zzso containing zzso zzso zzso zzso over 60 zzso The median zzso zzso 80 concentration was zzso zzso zzso zzso zzso Only one patient had a level of zzso zzso zzso Five patients received intravenous zzso at 120 zzso over zzso zzso zzso dose zzso zzso containing zzso zzso zzso zzso In the zzso plasma sample, zzso 80 was not zzso zzso zzso zzso in any zzso Plasma zzso 80 levels following an intravenous infusion of 120 zzso zzso or of zzso at doses used in Phase II trials, are insufficient to show zzso of zzso in zzso 

